Approval · Notice of Compliance 31015 · 2023
APO-NABILONE: Notice of Compliance 31015
Issued June 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31015
- Date
- June 19, 2023
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Replacement or addition of a manufacturing site and/or manufacturer involving: production of the starting material
- Canadian reference product
- CESAMET (Valeant Canada Lp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-NABILONE | Not yet assigned | — |